Kringle Pharma Competitors and Similar CompaniesClear all
Kringle Pharma's competitors and similar companies include Takeda, Pharmacyclics, PharmaEssentia and PLIVA.
 Kringle Pharma Kringle Pharma is a clinical-stage biopharmaceutical company that focuses on the research and development of regenerative medicines. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |  PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. |  PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | |
Founding Date | Founding Date 2001 | Founding Date 1781 | Founding Date 1991 | Founding Date 2003 | Founding Date 1921 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Ibaraki, JP HQ | Locations Sunnyvale, US HQ | Locations Taipei, TW HQ Shinjuku City, JP Burlington, US | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | |
Employees | Employees 13 | Employees 47,4554% decrease | Employees 6551% decrease | Employees 4897% increase | Employees 1,685 |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥72.2m (FY, 2025) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) NT$15.6b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $40.4m (FY, 2014) | Cost of goods NT$1.3b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥72.2m (FY, 2025) | Gross profit ¥3.8t (FY, 2025) | Gross profit $689.3m (FY, 2014) | Gross profit NT$14.4b (FY, 2025) | Gross profit N/A |
Net income | Net income (¥916.3m) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income $86.1m (FY, 2014) | Net income NT$5b (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 16.8m | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View companyPharmaEssentia
HQ
Taipei, TW
Employees
489↑ 7% increase
PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
View companyPLIVA
HQ
Zagreb, HR
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View company